C
Catherine M. Tangen
Researcher at Fred Hutchinson Cancer Research Center
Publications - 290
Citations - 28247
Catherine M. Tangen is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 54, co-authored 259 publications receiving 25256 citations.
Papers
More filters
Journal ArticleDOI
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
Daniel P. Petrylak,Catherine M. Tangen,Maha Hussain,Primo N. Lara,Jeffrey A. Jones,Mary-Ellen Taplin,Patrick A. Burch,Donna L. Berry,Carol M. Moinpour,Manish Kohli,Mitchell C. Benson,Eric J. Small,Derek Raghavan,E. David Crawford +13 more
TL;DR: The improvement in median survival of nearly two months with docetaxel and estramustine, as compared with mitoxantrone and prednisone, provides support for this approach in men with metastatic, androgen-independent prostate cancer.
Journal ArticleDOI
The Influence of Finasteride on the Development of Prostate Cancer
Ian M. Thompson,Phyllis J. Goodman,Catherine M. Tangen,M. Scott Lucia,Gary J. Miller,Leslie G. Ford,Michael M. Lieber,R. Duane Cespedes,JN Atkins,Scott M. Lippman,Susie M. Carlin,Anne Ryan,Connie M. Szczepanek,John Crowley,Charles A. Coltman +14 more
TL;DR: Finasteride prevents or delays the appearance of prostate cancer, but this possible benefit and a reduced risk of urinary problems must be weighed against sexual side effects and the increased risk of high-grade prostate cancer.
Journal ArticleDOI
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
Ian M. Thompson,Donna K. Pauler,Phyllis J. Goodman,Catherine M. Tangen,M. Scott Lucia,Howard L. Parnes,Lori M. Minasian,Leslie G. Ford,Scott M. Lippman,E. David Crawford,John Crowley,Charles A. Coltman +11 more
TL;DR: Biopsy-detected prostate cancer, including high-grade cancers, is not rare among men with PSA levels of 4.0 ng per milliliter or less--levels generally thought to be in the normal range.
Journal ArticleDOI
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
H. Barton Grossman,Ronald B. Natale,Catherine M. Tangen,V. O. Speights,Nicholas J. Vogelzang,Donald L. Trump,Ralph W deVere White,Michael F. Sarosdy,David P. Wood,Derek Raghavan,E. David Crawford +10 more
TL;DR: Using neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin followed by radical cystectomy increases the likelihood of eliminating residual cancer in the Cystectomy specimen and is associated with improved survival among patients with locally advanced bladder cancer.
Journal ArticleDOI
Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Eric A. Klein,Ian M. Thompson,Catherine M. Tangen,John Crowley,M. Scott Lucia,Phyllis J. Goodman,Lori M. Minasian,Leslie G. Ford,Howard L. Parnes,J. Michael Gaziano,Daniel D. Karp,Michael M. Lieber,Philip J. Walther,Laurence Klotz,J. Kellogg Parsons,Joseph L. Chin,Amy K. Darke,Scott M. Lippman,Gary E. Goodman,Frank L. Meyskens,Laurence H. Baker +20 more
TL;DR: Dietary supplementation with vitamin E significantly increased the risk of prostate cancer among healthy men in relatively healthy men.